Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
19,579 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | completed | Phase 2 | 65 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001430 | A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 |
| clinicaltrials |
| NCT00001446 | A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001450 | Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC | completed | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001475 | Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | completed | Phase 2 | 85 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001499 | Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001509 | A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001524 | Thalidomide to Treat Oral Lesions in HIV-Infected Patients | completed | Phase 2 | 110 | National Institute of Dental and Craniofacial Research (NIDCR)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001567 | A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001685 | Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase | completed | Phase 2 | 114 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001698 | Randomized, Double Blind, Placebo-Controlled, Phase IIB Trial of Ketorolac Mouth Rinse Evaluating the Effect of Cyclooxygenase Inhibition on Oropharyngeal Leukoplakia: Collaborative Study of the NCI, NIDCD and the NIDCR | completed | Phase 2 | 57 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001705 | Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence | completed | Phase 2 | 141 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001750 | Comparing Treatments for Multiple Myeloma | completed | Phase 2 | 32 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001805 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001839 | A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome | completed | Phase 2 | 182 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001860 | Sandostatin LAR Depot vs. Surgery for Treating Acromegaly | completed | Phase 2 | 5 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001862 | TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis | completed | Phase 2 | 15 | National Eye Institute (NEI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001877 | Treatment of Pulmonary Sarcoidosis With Pentoxifylline | completed | Phase 2 | 100 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001901 | Etanercept to Treat Wegener's Granulomatosis | completed | Phase 2 | 60 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001955 | Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions) | completed | Phase 2 | 150 | National Institute of Dental and Craniofacial Research (NIDCR)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00005926 | Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00006450 | Phenylbutyrate to Treat Children With Progressive or Recurrent Brain Tumors | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026858 | Total Body Irradiation for Bone Marrow Transplants: Collaborative Efforts | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026897 | Trafficking of Indium-III-Labeled Cultured Immune Cells in Patients Undergoing Immunotherapy for Advanced Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026936 | A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning | completed | Phase 2 | 140 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026962 | Effects of Raloxifene on Hormone Levels | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00080574 | The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients | completed | Phase 2 | 20 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00051974 | Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 155 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00051987 | Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma | completed | Phase 2 | 175 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00063713 | VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma | completed | Phase 2 | 152 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00064610 | Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer | completed | Phase 1 / Phase 2 | 102 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00085696 | VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma | completed | Phase 2 | 66 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00304720 | Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor | unknown | Phase 2 | 40 | Colorado Blood Cancer InstituteOTHER | 1 | Feb 8, 2008 | clinicaltrials |
| NCT00405574 | Study of ATN-224 in Patients With Prostate Cancer | unknown | Phase 2 | 50 | AttenuonINDUSTRY | 1 | Jan 30, 2008 | clinicaltrials |
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00265928 | Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma | terminated | Phase 2 | 46 | University of VirginiaOTHER | 1 | Jan 28, 2008 | clinicaltrials |
| NCT00065195 | REST: Reducing End-of-Life Symptoms With Touch | completed | Phase 2 | 440 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00079794 | Iscar for Supplemental Care in Stage IV Lung Cancer | completed | Phase 2 | 36 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00046371 | Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients | completed | Phase 2 | — | Oncothyreon Canada Inc.INDUSTRY | 1 | Jan 23, 2008 | clinicaltrials |
| NCT00087841 | Self-Hypnotic Relaxation Therapy During Invasive Procedures | completed | Phase 2 | 390 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00104468 | Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML) | terminated | Phase 1 / Phase 2 | 50 | SGX Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 17, 2008 | clinicaltrials |
| NCT00066196 | Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma | completed | Phase 2 | 110 | MedImmune LLCINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00072930 | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 2 | 150 | MedImmune LLCINDUSTRY | 7 | Jan 15, 2008 | clinicaltrials |
| NCT00082082 | A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma | completed | Phase 2 | — | SciClone PharmaceuticalsINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00090090 | Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 114 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Jan 15, 2008 | clinicaltrials |
| NCT00141700 | Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | terminated | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials